You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction
Free

http://dx.doi.org/10.1136/heartjnl-2014-306786corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    doi:10.1136/heartjnl-2014-306786corr1

    Tietjens J, Teerlink JR. Serelaxin and acute heart failure. Heart 2016;102:95–9. In this review the latest set of competing interests were not included in the published version. They are as follows; JT has no competing interests. JRT has received research grants and consulting fees from Amgen, Bayer, Cytokinetics, Novartis, and Trevena.

    Linked Articles

    • Review
      Serelaxin and acute heart failure
      Jeremy Tietjens John R Teerlink
      Heart 2015; 102 95-99 Published Online First: 24 Nov 2015. doi: 10.1136/heartjnl-2014-306786